IL‐13 was used in the current study since it is a key T helper 2 mediator in eliminating intestinal helminth infection via regulating goblet cell function to enhance mucosal barrier function.1, 10 During IL‐13 challenge, no significant augmentation of goblet cell‐related gene expression was observed with LAB treatment. This evidence concerns the gene IL13 and helminthiasis.